DNA Bridges, Inc - Corporate Strategy, Business Intelligence, Bioprocessing and Manufacturing

DNA Bridges, Inc. is committed to time-saving, cost-effective solutions to help achieve client objectives. Diverse technical and business expertise among our consultants creates a wide range of ideas and perspectives, which offer our clients a competitive advantage.

The DNA Bridges, Inc. team provides expert consulting and professional services to the life sciences, biotechnology, pharmaceutical and diagnostic industries. Strategic and operational solutions are based on more than 30 years' experience in industry. Experienced in: gene expression, recombinant protein production, patent portfolio management, cell culture manufacturing, clinical diagnostics and strategic planning.

DNA BRIDGES FOUNDERS

Cori Gorman, PhD, MBA
Corporate Strategy | Bioprocessing and Manufacturing

Eileen Gorman, PhD
Corporate Strategy | Diagnostics Project Leadership | Systems Integration | IP

DNA BRIDGES TEAM

L. Gene Burton, PhD
Bioprocessing and Manufacturing

Patricia Donahue, MBA
Pharmaceutical and Biotechnology Global Business Development

Cammie Edwards, PhD
Corporate Strategy

Greg Landes, PhD
Biotechnology Consultant

Robert Meister
Corporate Communications | Creative Services

Thomas O'Brien, PhD
Corporate Strategy | Market and Technology Opportunity Assessments

Dave Vetterlein, PhD
Bioprocessing and Manufacturing

STRATEGIC PARTNERS

Meaningful partnerships are the foundations for success. DNA Bridges, Inc. has established collaborative agreements with various US and European organizations ranging from regulatory expertise to law firms specializing in IP.

"They are the experts in their field. They definitely helped us achieve what we needed to achieve."

- Executive client in the pharmaceutical industry.

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.

OUR COMMERCIAL NETWORK

● BIO
● California Stem Cells Initiative
● Chatsworth
● EBD Group
● Haas Business School, UC Berkeley
● National Cancer Institute
● San Jose Incubator
● Science Futures
● Swiss Biotech Association
● Target Health
● Task Force Europe (Holland)
● UCLA Cancer Center
● UCSF
● University Colorado Health Science Center
● Amgen Bioprocessing Center (Keck Graduate Institute)